Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Bypass surgery beats coronary intervention in multivessel disease patients. Medical device excise tax repeal efforts criticized in NEJM commentary. More news.

You may also be interested in...

Clinical Lab And DME Payments Face Cuts Under Obama Budget

The 2014 federal budget request submitted by President Obama April 10 includes proposals to cut clinical lab services and to limit Medicaid reimbursement for durable medical equipment, among other cuts that would affect the medtech industry.

BD Makes Pharma Debut With Generic Prefilled Syringe

BD gained FDA approval for the first in a line of prefilled generic injectable drugs that will be marketed by its new subsidiary, BD Rx.

MedCAC Calls For More Evidence On Radiation Therapy For Prostate Cancer

CMS is unlikely to consider national coverage of radiation therapy for prostate cancer anytime soon because of insufficient evidence on the effectiveness of the treatment, according to Marcel Salive, director of medical and surgical services in CMS' Coverage and Analysis Group


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts